NCT05636800 is a NA clinical trial of Swift System in Keratosis, Actinic, sponsored by Blackwell Device Consulting.

Who is sponsoring NCT05636800?

NCT05636800 is sponsored by Blackwell Device Consulting.

What drugs are being tested in NCT05636800?

Interventions in NCT05636800: Swift System.

What condition does NCT05636800 study?

NCT05636800 studies Keratosis, Actinic.

Is NCT05636800 still recruiting?

NCT05636800 is currently active, enrolled. Last updated 6 August 2024.

Last reviewed 2024-08-06 · How we verify

NCT05636800

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Microwave Treatment for Actinic Keratosis

Active, enrolled NA Last updated 6 August 2024

What this trial tests

NA trial testing Swift System in Keratosis, Actinic in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

18 January 2023

Primary endpoint
1 November 2024

1 November 2024

Quick facts

Lead sponsor	Blackwell Device Consulting
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	18 January 2023
Primary completion	1 November 2024
Estimated completion	1 November 2024
Sites	2 locations across United States, Germany

Drugs / interventions tested

Swift System

Conditions studied

Keratosis, Actinic — all drugs for Keratosis, Actinic →

Sponsor

Blackwell Device Consulting

Who can join

Adults 18 to 85, any sex, with Keratosis, Actinic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, controlled, multi-center trial in subjects diagnosed with Actinic Keratosis (AK) where each subject serves as their own control. The trial will be conducted at 2 sites, one in Germany and one in the United States. Approximately 60 subjects will be randomized to ensure 51 subjects complete the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05636800 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Blackwell Device Consulting
Last refreshed: 6 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05636800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing